Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorUniversity Hospital, Basel, Switzerland
This study is to identify rare, disease-causing mutations of several rare neutrophil dermatoses. To identify associations between NMID and variants in the genome next generation sequencing, mainly whole exome sequencing, will be used. In a second approach the expression level of already known inflammatory proteins in skin samples will be investigated.
written consent of the participating person
diagnosis of a disease in the NMID form group or proband of the control group
Missing informed consent if samples collected after 2014
no diagnosis of NMID
Missing informed consent
University Hospital, Basel, Switzerland
Lead sponsor